Background
==========

Osteoarthritis (OA) is a degenerative disease characterized by chronic pain and movement disorders in the joints. The main pathological manifestations of OA include the progressive destruction of articular cartilage, osteophyte formation, subchondral bone sclerosis, and synovitis. OA is associated with many factors, such as obesity, inflammation, aging, genetic factors, and injuries \[[@b1-medscimonit-24-9177]\]. Previous studies have shown that the essential change in OA is loss of the articular cartilage matrix, which is induced by various factors, such as abnormal immune, genetic, and oxidative stress. It has been generally recognized that overexpression of reactive oxygen species (ROS) plays a key role in the degeneration of articular cartilage function \[[@b2-medscimonit-24-9177]\].

Oxidative stress is produced by a variety of ROS, including peroxynitrite, superoxide anions, nitric oxide (NO), and hydrogen peroxide (H~2~O~2~) \[[@b3-medscimonit-24-9177]\]. Excess hydrogen peroxide is known as a key mediator in the processes that damage cells, including chondrocytes \[[@b4-medscimonit-24-9177]\]. Sub-millimolar concentrations of H~2~O~2~ can induce inhibition of the extracellular matrix (ECM) synthesis, chondrocyte apoptosis, lipid peroxidation, and inflammatory cytokines overproduction, which further lead to the matrix metalloproteinase (MMPs) formation \[[@b5-medscimonit-24-9177]--[@b7-medscimonit-24-9177]\]. Thus, H~2~O~2~-induced oxidative stress may be helpful to study the occurrence and development of OA and evaluate the therapeutic strategies.

Previous studies have shown that hesperidin, a flavanone glycoside containing the flavanone hesperetin and the disaccharide rutinose, has anti-rheumatic activity in adjuvant arthritis (AA) or collagen-induced arthritis (CIA) rats \[[@b8-medscimonit-24-9177]--[@b11-medscimonit-24-9177]\]. In addition, several studies have shown that hesperidin has a definite anti-oxidative stress effect. For instance, Maekawa \[[@b12-medscimonit-24-9177]\] found that hesperidin can protect the retina against damage by suppressing oxidative stress and excessive calpain activation. Li \[[@b13-medscimonit-24-9177]\] confirmed that hesperidin ameliorates UV radiation-induced skin damage by abrogation of oxidative stress and inflammation in HaCaT cells.

Hesperidin also has a protective role against oxidative stress, injury, and apoptosis induced by γ-radiation in testes \[[@b14-medscimonit-24-9177]\]. However, it is not clear whether the anti-oxidative activity of hesperidin has a therapeutic effect on osteoarthritis. In the present study, we explored the protective effect of hesperidin on rat chondrocytes and its underlying mechanisms.

Material and Methods
====================

Reagents
--------

Hesperidin was obtained from Sigma-Aldrich (St. Louis, MO, USA). The purity of hesperidin was greater than 80%. Dulbecco's modified Eagle's medium/nutrient F-12 Ham (DMEM/F12) medium, 0.25% trypsin, and type II collagenase were from Thermo Fisher Scientific, Inc. (Waltham, MA, USA). CCK-8, RIPA lysis buffer, lipid peroxidation malondialdehyde (MDA) assay kit, and reactive oxygen species (ROS) assay kit were supplied by Beyotime Biotechnology (Nantong, China). Fetal bovine serum (FBS) was from GE Healthcare Life Sciences Hyclone Laboratories (Logan, UT, USA). The FITC Annexin V Apoptosis Detection Kit was supplied by BD Pharmingen (San Diego, CA, USA). RNAiso plus regent, PrimeScript RT Master Mix kit, and SYBR Premix Ex Taq II kit were from Takara Bio, Inc. (Shiga, Japan). Anti-IL-1β antibody (cat. no. ab9722), Anti-TNF-α antibody (cat. no. ab6671), and HRP/DAB detection IHC detection kit (cat. no. ab236469) were from Abcam (Cambridge, MA, USA). Dimethyl sulfoxide (DMSO) was obtained from MP Biomedicals (Santa Ana, CA, USA). Hesperidin was dissolved in DMSO to achieve the storage concentration of 10 ug/ul and diluted with DMEM/F12 medium to get the various working concentrations. DMEM/F12 medium was used to dissolve collagenase II to the concentration 2 mg/ml. The experiments were approved by the Ethics Committee of Nanjing Medical University.

Cell culture
------------

We obtained 1-week-old male Sprague-Dawley rats from the Animal Center of Nanjing Medical University (Nanjing, China). Rat chondrocytes were obtained as described previously \[[@b7-medscimonit-24-9177],[@b15-medscimonit-24-9177]\]. Briefly, cartilage from the knees of rats was minced into small pieces, then sequentially digested in 0.25% trypsin for 30 min and placed on 2 mg/ml collagenase II-containing medium for 4--5 h at 37°C. The solution was washed using phosphate-buffered saline (PBS) and filtered through a 200-μm cell strainer. The cells collected by centrifugation were cultured in DMEM/F12 medium containing 10% FBS at 37°C in a humidified 5% CO~2~ atmosphere. Chondrocytes at passage 2 were selected for the subsequent processes.

Cell viability assay
--------------------

CCK-8 assay was used to measure the cell viability. Briefly, cells were cultured in 96-well plates at a density of 1×10^4^ cells/well. After overnight adhesion, cells were appropriately treated according to the experimental grouping. Then, 10 μl CCK-8 solution/well was added before further incubation of cells for 1 h in a BB5060 incubator. A microplate reader was used to measure the absorbance of each well.

Cell apoptosis assay
--------------------

Sample cells were washed twice using cold PBS and adjusted to a concentration of 1×10^6^ cells/ml using binding buffer. We transferred 100 μl of the solution (1×10^5^ cells) to a 5-ml culture tube. Then, we added 5 μl FITC Annexin V and propidium iodide and incubated the mixture for 15 min in the dark at room temperature. The chondrocytes were analyzed using a FACScan flow cytometer.

Lipid peroxidation MDA assay
----------------------------

Treated cells were collected after washing with cold PBS. Then, RIPA lysis buffer was added to extract proteins for 5 min. Total cell lysate was centrifuged at 14 000×g for 5 min. BCA assay was used to determine the protein concentrations of samples. According to the kit's instructions, MDA levels were evaluated by thiobarbituric acid (TBA) test.

Reactive oxygen species detection
---------------------------------

According to the kit's instructions, cells were collected and washed with serum-free DMEM/F12 medium after appropriate treatment. The fluorescent probe DCFH-DA was added to cell suspension at a concentration of 10 μM. After incubation for 30 min in the BB5060 incubator, the cells were collected and washed with serum-free medium 3 times. The samples were analyzed by a FACScan flow cytometer.

Quantitative real-time PCR (qPCR) analysis
------------------------------------------

RNAiso plus regent was used to extract total RNA from samples, which was then transcribed into cDNA using a PrimeScript RT Master Mix kit. The primers for caspase 3, Col2a1, aggrecan, SOX9, MMP-13, iNOS, IL-1β, TNF-α, and β-actin were amplified using a SYBR Premix Ex Taq II kit in a Step One Plus Real-Time PCR system. The primer sequences are shown in [Table 1](#t1-medscimonit-24-9177){ref-type="table"}. The primers were synthesized by Shanghai GenePharma Co., Ltd. All the results were analyzed using the 2^−ΔΔCt^ method \[[@b16-medscimonit-24-9177]\].

Surgical Induction of OA
------------------------

Male Sprague-Dawley rats (6 weeks old) were divided into 2 groups: a hesperidin group and a control group (n=5 each). All rats were anesthetized with 10% chloral hydrate and the left knee underwent surgery. As previously reported \[[@b17-medscimonit-24-9177]\], the left knee joint was exposed through a medial capsular incision. Then, the medial collateral ligament was transected and the medial meniscus was removed. All of the rats received penicillin to prevent wound infection after the operation. None of the joints were infected during the experimental period. Two weeks after surgery, hesperidin (200 mg/kg body weight) or vehicle control was administered orally once a 118 day for 28 days \[[@b18-medscimonit-24-9177]\].

Histologic and immunohistochemical analysis
-------------------------------------------

Total knee joints from rats were fixed in 4% paraformaldehyde, then decalcified in EDTA and embedded in paraffin. Tissue sections of 5-μm thickness were stained using Safranin O/Fast green to determine proteoglycan depletion and cartilage destruction. To analyze IL-1β and TNF-α distribution in the cartilage, the sections were de-paraffinized and rehydrated in graded ethanol. After respective incubation with primary antibodies of IL-1β and TNF-α, the samples were treated according to the kit's instruction. Finally, the sections were observed under a microscope. The stained sections were analyzed using ImageJ 1.43 software (*[imagej.nih.gov](https://imagej.nih.gov)*).

Statistical analysis
--------------------

Statistical analyses were performed with SPSS 15.0 software (SPSS Inc., Chicago, IL, USA) or GraphPad Prism (GraphPad Software, San Diego, CA, USA). CCK-8 assay, cell apoptosis assay, MDA assay, ROS detection, and qPCR analysis data were analyzed using one-way ANOVA followed by Dunnett's multiple comparisons. Histologic and immunohistochemistry analysis data were assessed using the unpaired *t* test. A p value of \<0.05 was considered statistically significant.

Results
=======

Effect of hesperidin on cell viability
--------------------------------------

Chondrocytes were incubated with different concentrations of hesperidin (0, 0.001, 0.01, 0.1, 1, and 10 μg/ml) for 24 h. Then, the CCK-8 assay was used to evaluate the effect of hesperidin on cell viability. The data confirmed that concentrations of hesperidin in this range did not significantly affect cell viability ([Figure 1A](#f1-medscimonit-24-9177){ref-type="fig"}). H~2~O~2~ treatment (0, 100, 200, 300, 400, and 500 μM for 24 h) induced a dose-dependent reduction in chondrocytes viability. A 50% inhibition concentration value (IC50) was observed at 230 μM ([Figure 1B](#f1-medscimonit-24-9177){ref-type="fig"}). Hesperidin (0.1 and 1 μg/mL) attenuated the changes in cell viability induced by 230 μM H~2~O~2~ ([Figure 1C](#f1-medscimonit-24-9177){ref-type="fig"}). The optimal concentration of hesperidin (0.1 μg/mL) was selected for further experiments.

Effect of hesperidin on chondrocytes apoptosis
----------------------------------------------

Flow cytometry assay was used to measure chondrocyte apoptosis ([Figure 2A--2D](#f2-medscimonit-24-9177){ref-type="fig"}). Cells were treated with 0.1 μg/mL hesperidin for 2 h before 230 μM H~2~O~2~ treatment for 24 h. The cells in the negative control group were treated with medium alone for 24 h, and the cells in the positive control group were treated with 230 μM H~2~O~2~ alone for 24 h. The results ([Figure 2D](#f2-medscimonit-24-9177){ref-type="fig"}) showed that the percentage of apoptotic chondrocytes in the hesperidin-pretreated group was significantly decreased compared to that in the 230 μM H~2~O~2~ alone group (p\<0.05). Stimulation with 230 μM H~2~O~2~ led to a significant increase in caspase-3 gene expression, which was alleviated by hesperidin pretreatment (0.1 μg/mL) (p\<0.05, [Figure 2E](#f2-medscimonit-24-9177){ref-type="fig"}).

Antioxidant capacity of hesperidin in H~2~O~2~-treated chondrocytes
-------------------------------------------------------------------

Lipid oxidation and ROS formation occur when cells undergo oxidative stress. Our data show that 230 μM H~2~O~2~ significantly increased the MDA levels compared to the medium alone group (p\<0.05). However, pretreatment with hesperidin (0.1 μg/mL) significantly reduced the levels of MDA equivalents ([Figure 3A](#f3-medscimonit-24-9177){ref-type="fig"}). Exposure of chondrocytes to 230 μM H~2~O~2~ plus 0.1 μg/mL hesperidin remarkably reduced the intracellular ROS formation compared with 230 μM H~2~O~2~ alone ([Figure 3B--3D](#f3-medscimonit-24-9177){ref-type="fig"}).

Effect of hesperidin on chondrogenic and inflammatory gene expression
---------------------------------------------------------------------

The gene expression of aggrecan, Col2a1, and SOX9 was decreased in chondrocytes treated with 230 μM H~2~O~2~ alone ([Figure 4A--4C](#f4-medscimonit-24-9177){ref-type="fig"}), while the gene expression of IL-1β, TNFα, iNOS, and MMP13 was increased ([Figure 4D--4G](#f4-medscimonit-24-9177){ref-type="fig"}), compared with normal chondrocytes (p\<0.05). Hesperidin alleviated downregulation of aggrecan, Col2a1, and SOX9 induced by H~2~O~2~ and suppressed induction of IL-1β, TNFα, iNOS, and MMP13 compared with H~2~O~2~ alone (p\< 0.05). These results show that hesperidin alleviated H~2~O~2~-induced inflammation and improved the recovery of injury in chondrocytes.

Protective effect of hesperidin on cartilage destruction in a surgically-induced OA model
-----------------------------------------------------------------------------------------

To observe whether hesperidin protects against cartilage destruction, OA was surgically induced in rats. After hesperidin or a vehicle control was orally administered, the sections obtained from rat knee joints were stained using Safranin O/Fast green to observe histological changes. In [Figure 5B](#f5-medscimonit-24-9177){ref-type="fig"}, the red color of cartilage tissue was obviously darker and the integrity of cartilage structure was better than that in [Figure 5A](#f5-medscimonit-24-9177){ref-type="fig"}, illustrating increased cartilage proteoglycan depletion in the control group without hesperidin treatment ([Figure 5C](#f5-medscimonit-24-9177){ref-type="fig"}). IL-1β ([Figure 5D, 5E](#f5-medscimonit-24-9177){ref-type="fig"}) and TNF-α ([Figure 5G, 5H](#f5-medscimonit-24-9177){ref-type="fig"}) levels were also analyzed by immunohistochemistry. More IL-1β-positive areas ([Figure 5D](#f5-medscimonit-24-9177){ref-type="fig"}) and TNF-α-positive areas ([Figure 5G](#f5-medscimonit-24-9177){ref-type="fig"}) were found in the control group compared to those in the hesperidin group ([Figure 5E, 5H](#f5-medscimonit-24-9177){ref-type="fig"}), illustrating decreased inflammatory cytokines expression after hesperidin treatment ([Figure 5F, 5I](#f5-medscimonit-24-9177){ref-type="fig"}).

Discussion
==========

With the aging of the population, the prevalence of OA is also rising. In China, epidemiological surveys show that the prevalence of OA in the population is about 4%, while the incidence of knee osteoarthritis in people over 60 years old is as high as 42.8% \[[@b19-medscimonit-24-9177]\]. Therefore, research on OA is very important and has great social benefits. In this study, we evaluated the antioxidant effect of hesperidin against H~2~O~2~-induced rat chondrocytes reactions and confirmed that hesperidin can restore the metabolic balance of OA. H~2~O~2~ can be endogenously produced in the pathogenesis of OA and can induce chondrocyte injury \[[@b20-medscimonit-24-9177]\]. Our study found that inhibition of rat chondrocyte proliferation increased dose-dependently with H~2~O~2~ concentration but was significantly decreased by supplementation of hesperidin, and the concentration of 0.1 ug/ml hesperidin had the best effect in this process. Furthermore, FITC Annexin V/PI staining revealed that hesperidin suppressed chondrocyte apoptosis induced by H~2~O~2~ *in vitro*. Meanwhile, the gene expression of caspase-3, a crucial biomarker of apoptosis, also could be reduced after hesperidin treatment under H~2~O~2~ induction. Previous studies have shown that chondrocyte apoptosis induced by oxidative stress is responsible for the development of OA \[[@b21-medscimonit-24-9177]--[@b23-medscimonit-24-9177]\]. This observation may indicate that hesperidin can attenuate the progression of OA through suppression of H~2~O~2~-mediated injury. Through the detection of cellular ROS and MDA, we also assessed whether hesperidin has antioxidant effects and inhibits oxidative stress. We assessed ROS flow cytometry assays, and MDA, a natural product of lipid peroxidation, was assessed by TBA test. Lipid peroxidation can be induced by ROS and causes significant tissue damage in degenerative osteoarthritis \[[@b24-medscimonit-24-9177]--[@b27-medscimonit-24-9177]\]. Our data confirmed that H~2~O~2~-mediated oxidative stress can enhance ROS and lipid peroxidation levels in chondrocytes, which was clearly suppressed by hesperidin. NO, an oxygen free radical accumulating in the articular tissue of patients with osteoarthritis, induces cartilage degeneration. *In vivo*, NO is produced in the process of oxidative oxidation of L-arginine to L-citrulline by iNOS. Thus, the content of iNOS in chondrocytes may play an important role in the course of osteoarthritis. Our results showed that elevated gene expression of iNOS due to hydrogen peroxide can be inhibited by hesperidin, suggesting that hesperidin slows the progression of osteoarthritis.

Inflammatory cytokines play a key role in the pathogenesis of arthritis, and IL-1β and TNF-α are the 2 most important factors \[[@b28-medscimonit-24-9177]--[@b30-medscimonit-24-9177]\]. Related research has confirmed that oxidative stress and inflammatory responses are closely related in arthritis \[[@b31-medscimonit-24-9177]--[@b33-medscimonit-24-9177]\]. Our *in vitro* experimental results showed that oxidative stress can lead to significantly increased gene expression of TNF-α and IL-1β, and hesperidin treatment significantly alleviated this inflammatory response. Chondrocyte ECM mainly contains type 2 collagen and aggrecan. The degradation of ECM is a prominent feature of OA, and MMPs are the major enzymes responsible for the ECM degradation of OA chondrocytes \[[@b34-medscimonit-24-9177],[@b35-medscimonit-24-9177]\]. In the MMPs family, MMP-13 has the strongest ability to degrade type 2 collagen \[[@b36-medscimonit-24-9177]\]. SOX9 is an important transcriptional regulator during chondrogenesis \[[@b37-medscimonit-24-9177]\]. Col2a1 expression in chondrocytes is positively correlated with SOX9 concentration, confirming that Col2a1 is a SOX9-dependent chondrocyte proliferation gene regulator \[[@b38-medscimonit-24-9177]\]. In our research, we observed that MMP-13 gene expression in chondrocytes were significantly increased after H~2~O~2~ treatment, while chondrogenic genes (Col2a1, aggrecan, and SOX9) expression were clearly depressed. However, the tendency was changed after hesperidin treatment, which suggested that damaged chondrocytes were protected against oxidative stress.

Since *in vitro* experiments have confirmed that hesperidin inhibits cell apoptosis and inflammatory cytokines expression caused by hydrogen peroxide, we further assessed whether hesperidin has therapeutic effects on OA *in vivo*. In an experimental rat model of OA, histologic and immunohistochemical analysis showed that hesperidin administration clearly prevented progression of cartilage destruction. Pathological sections showed that cartilage degeneration was significantly improved and inflammatory cytokines expression was reduced after hesperidin treatment.

Conclusions
===========

These findings suggest that hesperidin can prevent H~2~O~2~-induced chondrocytes injury through its antioxidant effects *in vitro* and reduced cartilage damage in a rat model of OA. These results support the potential therapeutic applications of hesperidin as a supplementation in human OA treatment.
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![Effect of hesperidin on rat chondrocytes viability and H~2~O~2~-induced reduction. The viability of chondrocytes in different groups was assessed by CCK-8 assay. (**A**) After adherence, cells were treated with 0, 0.001, 0.01, 0.1, 1, or 10 μg/mL of hesperidin for 2 h. (**B**) The dose-dependent effects of H~2~O~2~ on cell viability after 24 h treatment. The 50% inhibition concentration value (IC50) was found to be 230 μM. \*p\<0.05, compared with the 0 μM H~2~O~2~ group. (**C**) Hesperidin (0, 0.001, 0.01, 0.1, 1, or 10 μg/mL) was added for 2 h prior to 24 h treatment with 230 μM H~2~O~2~. \* p\<0.05, compared with the H~2~O~2~ group. All data are expressed as the mean ± standard deviation.](medscimonit-24-9177-g001){#f1-medscimonit-24-9177}

![Protective effect of hesperidin on chondrocyte apoptosis. FITC Annexin V/PI staining and flow cytometry assays were used to detect cell apoptosis. (**A**) Chondrocytes were cultured in DMEM/F12 medium for 24 h. (**B**) Chondrocytes were pretreated with 0.1 μg/ml hesperidin for 2 h and then incubated with 230 μM H~2~O~2~ for 24 h. (**C**) Chondrocytes were treated with 230 μM H~2~O~2~ for 24 h. (**D**) Chondrocyte apoptosis measured by flow cytometry is represented by bar graphs. (**E**) Effect of hesperidin on H~2~O~2~-induced gene expression of caspase 3. All data are expressed as the mean ± standard deviation. ^\#^ p\<0.05, compared with the control group. \* P\<0.05, compared with the H~2~O~2~ group.](medscimonit-24-9177-g002){#f2-medscimonit-24-9177}

![Antioxidant capacity of hesperidin in H~2~O~2~-treated chondrocytes. Chondrocytes were pretreated with hesperidin (0.1 μg/mL) for 2 h and incubated with 230 μM H~2~O~2~ for 24 h. (**A**) Total proteins were extracted to detect MDA equivalents. (**B**) Effect of hesperidin on intracellular reactive oxygen species (ROS) in chondrocytes. Intracellular ROS were measured by flow cytometry using an oxidation-sensitive fluorescent probe, DCFH-DA, which is oxidized to DCF in the presence of ROS. (**C**) ROS level measured by flow cytometry is represented by the relative DCF intensity. (**D**) Microscopic images showing the preventive effect of hesperidin against H~2~O~2~-induced ROS generation by DCFH-DA staining. H~2~O~2~ treatment significantly increased the levels of ROS, while hesperidin pretreatment significantly decreased the levels of ROS. Original magnification ×100. All data are expressed as the mean ± standard deviation. ^\#^ p\<0.05, compared with the control group. \* P\<0.05, compared with the H~2~O~2~ group.](medscimonit-24-9177-g003){#f3-medscimonit-24-9177}

![(**A--G**) Effect of hesperidin on H~2~O~2~-induced gene expression of aggrecan, Col2a1, SOX9, IL-1β, TNFα, iNOS, and MMP13 in chondrocytes. Chondrocytes were pretreated with 0.1 μg/ml hesperidin for 2 h and then incubated with 230 μM H~2~O~2~ for 24 h or with H~2~O~2~ alone. Total RNA was extracted, followed by RT-qPCR for detection of relative gene expression levels. All data are expressed as the mean ± standard deviation. ^\#^ p\<0.05, compared with the control group. \* P\<0.05, compared with the H~2~O~2~ group.](medscimonit-24-9177-g004){#f4-medscimonit-24-9177}

![Representative images of Safranin O/Fast green stained and immunohistochemical sections obtained from knee joints after surgically-induced osteoarthritis. Safranin O/Fast green stained sections from rats in control group (**A**) and hesperidin group (**B**). (**C**) Bar graphs represent mean percentage of Safranin O-positive area in each group. \* p\<0.05 compared with the control group. The cartilage degenerations were ameliorated in hesperidin group compared with those in control group, illustrating increased cartilage proteoglycan depletion in control group. Original magnification×40. Images of immunohistochemical staining for IL-1β in control group (**D**) and in hesperidin group (**E**). Images of immunohistochemical staining for TNF-α in control group (**G**) and in hesperidin group (**H**). IL-1β and TNF-α positive area are stained brown. Bar graphs represent mean percentage of IL-1β-positive area (**F**) and TNF-α-positive area (**I**) in each group. \*p\<0.05 compared with the control group. Original magnification ×100.](medscimonit-24-9177-g005){#f5-medscimonit-24-9177}

###### 

Sequences of primers for the quantitative RT-PCR experiments.

  Gene        Sense                    Sequence 5′→3′
  ----------- ------------------------ --------------------------
  β-actin     F                        GCAGAAGGAGATTACTGCCCT
  R           GCTGATCCACATCTGCTGGAA    
  iNOS        F                        CCCTTCCGAAGTTTCTGGCAGCAG
  R           GGGCTCCTCCAAGGTGTTGCCC   
  MMP-13      F                        AGGCCTTCAGAAAAGCCTTC
  R           GAGCTGCTTGTCCAGGTTTC     
  Aggrecan    F                        CCCTACCCTTGCTTCTCCA
  R           CTTGAGAGGCACTCATCAATGT   
  Col2A1      F                        GGCTCCCAGAACATCACCTA
  R           GCCCTCATCTCCACATCATT     
  SOX9        F                        AGAGCGTTGCTCGGAACTGT
  R           TCCTGGACCGAAACTGGTAAA    
  IL-1β       F                        CTGTGACTCGTGGGATGATG
  R           GGGATTTTGTCGTTGCTTGT     
  TNFα        F                        CTCCCAGAAAAGCAAGCAAC
  R           CGAGCAGGAATGAGAAGAGG     
  Caspase 3   F                        GCTGGACTGCGGTATTGAGA
  R           CCATGACCCGTCCCTTGA       
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